Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics -April 03, 2024 at 08:03 am EDT

Agilent Technologies Inc. , a global leader in life sciences and diagnostics, announced today its participation in the American Association for Cancer Research Annual Meeting . At the meeting, which...

Related Keywords

United States ,San Diego ,California ,London ,City Of ,United Kingdom ,American ,Marc Gunter ,Bob Mcmahon ,Bellal Moghis ,Novocyte Opteon ,Agilent Suredesign ,Somalogic Somascan ,Agilent Avida ,Agilent Novocyte Opteon ,Caroline Germa ,Karl Smith Byrne ,Agilent Technologies Inc ,Genomics Group ,Facebook ,American Association For Cancer Research Annual Meeting ,Imperial College London ,Oxford University ,Agilent Technologies ,American Association ,Cancer Research Annual Meeting ,Novocyte Opteon Spectral Flow Cytometer ,Agilent Novocyte Opteon Spectral Flow Cytometer ,Sureselect Cancer Custom ,Sureselect Cancer ,Med Tissue ,Med Heme ,Agilent Sureselect ,Transcenta Therapeutics ,Transcenta Therapeutic Osemitamab ,Markets ,